PND19 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN EUROPE
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1292
https://www.valueinhealthjournal.com/article/S1098-3015(19)31484-6/fulltext
Title :
PND19 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN EUROPE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31484-6&doi=10.1016/j.jval.2019.04.1292
First page :
Section Title :
Open access? :
No
Section Order :
10796